Yang Zhiru, Bjorkman Pamela J
Division of Biology 114-96 and Howard Hughes Medical Institute, California Institute of Technology, Pasadena, CA 91125, USA.
Proc Natl Acad Sci U S A. 2008 Jul 22;105(29):10095-100. doi: 10.1073/pnas.0804551105. Epub 2008 Jul 15.
UL18 is a human cytomegalovirus class I MHC (MHCI) homolog that binds the host inhibitory receptor LIR-1 and the only known viral MHC homolog that presents peptides. The 2.2-A structure of a LIR-1/UL18/peptide complex reveals increased contacts and optimal surface complementarity in the LIR-1/UL18 interface compared with LIR/MHCI interfaces, resulting in a >1,000-fold higher affinity. Despite sharing only approximately 25% sequence identity, UL18's structure and peptide binding are surprisingly similar to host MHCI. The crystal structure suggests that most of the UL18 surface, except where LIR-1 and the host-derived light chain bind, is covered by carbohydrates attached to 13 potential N-glycosylation sites, thereby preventing access to bound peptide and association with most MHCI-binding proteins. The LIR-1/UL18 structure demonstrates how a viral protein evolves from its host ancestor to impede unwanted interactions while preserving and improving its receptor-binding site.
UL18是一种人类巨细胞病毒I类主要组织相容性复合体(MHC I)同源物,它与宿主抑制性受体LIR-1结合,是唯一已知的呈递肽段的病毒MHC同源物。LIR-1/UL18/肽复合物的2.2埃结构显示,与LIR/MHC I界面相比,LIR-1/UL18界面的接触增加且表面互补性最佳,导致亲和力提高了1000倍以上。尽管UL18与宿主MHC I的序列同一性仅约为25%,但其结构和肽结合却惊人地类似于宿主MHC I。晶体结构表明,除了LIR-1和宿主来源的轻链结合的位置外,UL18的大部分表面都被连接在13个潜在N-糖基化位点上的碳水化合物覆盖,从而阻止了对结合肽的接触以及与大多数MHC I结合蛋白的结合。LIR-1/UL18结构展示了一种病毒蛋白如何从其宿主祖先进化而来,在保留并改善其受体结合位点的同时,阻碍不必要的相互作用。